| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |